{
  "id": 7337554,
  "title": "Electra aims for nearly $300M IPO; Enhertu's Phase 3 lung cancer success",
  "url": "https://urgent.news/2026/09/14/electra-aims-for-nearly-300m-ipo-enhertus-phase-3-lung-cancer-success",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-14T14:51:11.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/electra-aims-for-nearly-300m-ipo-enhertus-phase-3-lung-cancer-success/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus news about Lilly, Cellectis, Tyra, Shennon and QL Biopharm. Electra Therapeutics eyes $297M IPO: The Sanofi-backed biotech hopes to kick off the post-Labor Day IPO train with a nearly $300 million ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}